Samuel Perry

Samuel Perry has a diverse work experience in the biotech and medical research industry. Samuel is currently the Senior Director of Operations at Remix Therapeutics, a position they have held since November 2022. Before that, they were the Director of Laboratory & Facilities Operations at Ensoma starting from April 2021. Prior to that, Samuel worked at Compass Therapeutics LLC for several years, first as an Associate Director of Operations from September 2015 to October 2018, and then as a Senior Director of Operations from October 2018 to April 2021. Samuel started their career at Harvard Medical School as a Research Technician II in January 2006 before moving on to the Dana-Farber Cancer Institute as a Research Technician and later as a Senior Research Technician. Samuel also worked at MedImmune as both an Associate Scientist and R&D Associate from November 2010 to August 2015.

Samuel Perry completed their education with a Bachelor of Science (B.S.) in Neuroscience from St. Lawrence University in 2005. Samuel then pursued a Master of Science (M.S.) in Biotechnology and a Master of Business Administration (MBA) from The Johns Hopkins University - Carey Business School, completing both degrees in 2014.